Concepedia

Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events

Kohki Nakamura, Shigeto Naito, Takehito Sasaki, Yutaka Take, Kentaro Minami, Yoshiyuki Kitagawa, Hiroyuki Motoda, Mitsuho Inoue, Yoshimitsu Otsuka, Katsura Niijima,

EP Europace · 2018 · 63 citations · 19 references

DOIFull text

Open access

Abstract

Both the uninterrupted and interrupted DOAC protocols revealed a low risk of symptomatic thromboembolisms and major bleeding events and similar incidence of SCILs and minor bleeding events and may be feasible for periprocedural anticoagulation in NVAF patients undergoing catheter ablation.

References

19

2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society

Hugh Calkins, Karl Heinz Kuck, Riccardo Cappato et al. · EP Europace · 2012 · 2.7K citations · Full text

Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management

Luigi Di Biase, J. David Burkhardt, Pasquale Santangeli et al. · Circulation · 2014 · 480 citations · Full text

Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation

Hugh Calkins, Stephan Willems, Edward P. Gerstenfeld et al. · New England Journal of Medicine · 2017 · 431 citations · Full text

Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation

Riccardo Cappato, Francis E. Marchlinski, Stefan H. Hohnloser et al. · European Heart Journal · 2015 · 426 citations · Full text

Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation

Dhanunjaya Lakkireddy, Yeruva Madhu Reddy, Luigi Di Biase et al. · Journal of the American College of Cardiology · 2012 · 357 citations

, , +13